Cart
sales@molnova.com
YM976
CAS No. 191219-80-4
YM976( —— )
Catalog No. M21141 CAS No. 191219-80-4
YM976 is an orally active PDE4 inhibitor (IC50:2.2 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 51 | In Stock |
|
| 5MG | 41 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 110 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYM976
-
NoteResearch use only, not for human use.
-
Brief DescriptionYM976 is an orally active PDE4 inhibitor (IC50:2.2 nM).
-
DescriptionYM976 is an orally active PDE4 inhibitor (IC50:2.2 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number191219-80-4
-
Formula Weight313.78
-
Molecular FormulaC17H16ClN3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCc1ccc2c(-c3cccc(Cl)c3)nc(=O)n(CC)c2n1
-
Chemical Name4-(3-chlorophenyl)-17-diethyl-1H2H-pyrido[23-d]pyrimidin-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Aoki M Kobayashi M Ishikawa J et al. A Novel Phosphodiesterase Type 4 Inhibitor YM976 (4-(3-Chlorophenyl)-17-diethylpyrido[23-d]pyrimidin-2(1H)-one) with Little Emetogenic Activity[J]. Journal of Pharmacology & Experimental Therapeutics 2000 295(1):255-260.
molnova catalog
related products
-
CRT0273750
CRT0273750 regulates plasma LPA levels and is suitable for in vivo studies. CRT0273750 is an autotaxin (ATX) inhibitor with IC50 of 0.014 μM.
-
N-Ethyl tadalafil
N-Ethyl tadalafil (NEthyl tadalafil) is a CGMP-specific 3',5'-cyclic phosphodiesterase (PDE) inhibitor used in the study of cardiovascular diseases such as angina pectoris, hypertension, and pulmonary hypertension.
-
MBCQ
MBCQ is an inhibitor of cGMP-specific phosphodiesterase PDE5.MBCQ, a selective PDE5 inhibitor, significantly decreased the EC(50) values for GTN-induced relaxation in both tolerant and nontolerant tissues, but with the greatest relative shift occurring in tolerant veins.
